GlobeNewswire 21.11.2017 AC Immune to Host Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzhei...

GlobeNewswire 13.11.2017 AC Immune SA Reports Third Quarter 2017 Financial Results and Corporate Update

GlobeNewswire 02.11.2017 AC Immune SA to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 2 Trial for Alzhei...

GlobeNewswire 24.10.2017 AC Immune to Present at Two Investor Conferences and Provide Scientific Updates at CTAD Conference

GlobeNewswire 03.10.2017 AC Immune Awarded Continuation of 2015 Grant from The Michael J. Fox Foundation for Parkinson's Rese...

GlobeNewswire 12.09.2017 AC IMMUNE COMPLETES RECRUITMENT FOR LOW-DOSE COHORT IN WORLD'S FIRST CLINICAL TRIAL FOR ANTI-ABETA ...

GlobeNewswire 22.08.2017 AC IMMUNE DISCOVERS NEXT-GENERATION ANTIBODIES FOCUSED ON NEURODEGENERATIVE DISEASES

GlobeNewswire 09.08.2017 AC IMMUNE REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS

GlobeNewswire 10.07.2017 AC IMMUNE PROVIDES SEVEN UPDATES ON ITS PIPELINE AND TECHNOLOGY AT THE ALZHEIMER'S ASSOCIATION INTER...

GlobeNewswire 28.06.2017 AC IMMUNE ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING

GlobeNewswire 22.05.2017 AC IMMUNE AND ESSEX BIO-TECHNOLOGY ANNOUNCE RESEARCH COLLABORATION FOR NEURODEGENERATIVE DISEASES AN...